0001209191-13-037018.txt : 20130717 0001209191-13-037018.hdr.sgml : 20130717 20130717164000 ACCESSION NUMBER: 0001209191-13-037018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130715 FILED AS OF DATE: 20130717 DATE AS OF CHANGE: 20130717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stamoulis Christiana CENTRAL INDEX KEY: 0001502917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 13972937 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-07-15 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001502917 Stamoulis Christiana C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 SVP, Corp Strategy & Bus Devlp Common Stock 2013-07-15 4 M 0 1125 33.82 A 41837 D Common Stock 2013-07-15 4 S 0 1025 86.25 D 40812 D Common Stock 2013-07-15 4 S 0 100 87.33 D 40712 D Common Stock 939 I 401(k) Stock Option 33.82 2013-07-15 4 M 0 1125 0.00 D 2020-07-13 Common Stock 1125 4500 D Transaction made pursuant to Ms. Stamoulis' company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $86.25 (range $85.96 to $86.55). Ms. Stamoulis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. The option vests in 16 quarterly installments from 07/14/2010. Kenneth L. Horton, Attorney-In-Fact 2013-07-17